RNAループを閉じることで、より安定した効果的なRNA治療が期待できる(Closing the RNA Loop Holds Promise for More Stable, Effective RNA Therapies)

ad

2024-08-26 カリフォルニア大学サンディエゴ校(UCSD)

カリフォルニア大学サンディエゴ校の研究者が、RNA分子を円形にする新しい方法を開発し、より効果的で長持ちするRNA治療法の可能性を示しました。従来のRNA療法は体内での効果が短期間であるという課題がありましたが、円形RNA(cRNA)は分解されにくく、その安定性が向上します。研究チームは、細胞内で自然に起こるタンパク質RtcBと細菌酵素を利用してcRNAを作成する簡便でスケーラブルな方法を開発しました。これにより、心筋細胞や神経細胞において、従来の直線RNAよりも優れた安定性と生物活性を示し、心臓や神経系の疾患治療に有望な可能性を示しています。

<関連情報>

試験管内および人工的に環状化されたRNAを用いた頑健なゲノムおよび細胞工学 Robust genome and cell engineering via in vitro and in situ circularized RNAs

Michael Tong,Nathan Palmer,Amir Dailamy,Aditya Kumar,Hammza Khaliq,Sangwoo Han,Emma Finburgh,Madeleine Wing,Camilla Hong,Yichen Xiang,Katelyn Miyasaki,Andrew Portell,Joseph Rainaldi,Amanda Suhardjo,Sami Nourreddine,Wei Leong Chew,Ester J. Kwon & Prashant Mali
Nature Biomedical Engineering  Published:26 August 2024
DOI:https://doi.org/10.1038/s41551-024-01245-z

RNAループを閉じることで、より安定した効果的なRNA治療が期待できる(Closing the RNA Loop Holds Promise for More Stable, Effective RNA Therapies)

Abstract

Circularization can improve RNA persistence, yet simple and scalable approaches to achieve this are lacking. Here we report two methods that facilitate the pursuit of circular RNAs (cRNAs): cRNAs developed via in vitro circularization using group II introns, and cRNAs developed via in-cell circularization by the ubiquitously expressed RtcB protein. We also report simple purification protocols that enable high cRNA yields (40–75%) while maintaining low immune responses. These methods and protocols facilitate a broad range of applications in stem cell engineering as well as robust genome and epigenome targeting via zinc finger proteins and CRISPR–Cas9. Notably, cRNAs bearing the encephalomyocarditis internal ribosome entry enabled robust expression and persistence compared with linear capped RNAs in cardiomyocytes and neurons, which highlights the utility of cRNAs in these non-dividing cells. We also describe genome targeting via deimmunized Cas9 delivered as cRNA and a long-range multiplexed protein engineering methodology for the combinatorial screening of deimmunized protein variants that enables compatibility between persistence of expression and immunogenicity in cRNA-delivered proteins. The cRNA toolset will aid research and the development of therapeutics.

医療・健康
ad
ad
Follow
ad
タイトルとURLをコピーしました